MCK Forensic analysis

Trading Setup & Entry Strategy

MCK is currently in a bearish consolidation phase following a sharp -9.54% drop over the last 20 days. While the MACD remains bullish (histogram +2.19), the price is trading below both the 50-day SMA ($844.54) and 200-day SMA ($815.68), signaling a technical Death Cross/Bearish Trend. We are not chasing this downside; we are looking for a structural floor.

• >Entry Zone: Scale in at $745.00 - $755.00 (Current support zone near 10-day SMA).
• >Stop Loss: $705.00 (Hard stop below the Lower Bollinger Band at $706.25 to prevent catastrophic breakdown).
• >Position Sizing: 3% of portfolio.
• >Take Profit Levels: Target $815.00 (200-day SMA resistance) and $845.00 (50-day SMA recovery).
• >Risk/Reward: Target return ~$80/share vs risk ~$45/share = ~1:1.75 R/R.

Recent Material Events (8-K Analysis)

• >4/20/26: Announced Apollo Funds will acquire a 13% minority stake in the Medical-Surgical Solutions segment for $1.25B via convertible preferred equity. This validates the SOTP (Sum-of-the-Parts) valuation.
• >4/24/26: Executed new $5.00B 5-Year Credit Facility, providing ample liquidity to navigate potential sector volatility.

Insider Trading & Business Health

• >Insider Activity: No major sell-offs detected; management focus remains on the Medical-Surgical separation strategy.
• >Forensic Flags: Receivables quality remains stable, but Customer Concentration is a major risk: CVS Health (24% of revenue) remains a critical dependency.

Technical Analysis & Trade Timing

• >RSI (38.40): The stock is drifting toward oversold territory. This is a "Value Trap" watch zone. The Bearish Cross of the 50/200 SMA is a primary technical headwind. The current price ($761.89) is well below major moving averages, suggesting a recovery attempt will face significant overhead supply.

Short-Term Trading Strategy (2-5 Days)

• >Recommended Timeframe: Swing Trade (2–5 Days).
• >Scaling Strategy: Enter 30% at $755, add 40% at $747 (10-day SMA support), final 30% at $730 (on deep retest).
• >Max Hold: 2 weeks.
• >Catalyst: Watch for any stabilization in CVS contract renewal sentiment or positive analyst commentary regarding the Medical-Surgical spin-off.

Investment Recommendation: HOLD. The fundamental strength of the Medical-Surgical spin-off catalyst is high, but the technical trend is currently too weak to justify an aggressive BUY. Wait for the price to reclaim the $800 psychological level to invalidate the bearish momentum.